Reply to Rituxan is not associated with Stevens-Johnson syndrome

Ann Oncol. 2012 Mar;23(3):807. doi: 10.1093/annonc/mdr629. Epub 2012 Jan 19.

Authors

L Parise¹, J Kahle¹, M Schlaak¹, C Mauch¹, P Kurschat²

Affiliations

¹ Department of Dermatology, Skin Cancer Centre, University Hospital of Cologne, Cologne, Germany.
² Department of Dermatology, Skin Cancer Centre, University Hospital of Cologne, Cologne, Germany. Electronic address: peter.kurschat@uk-koeln.de.

PMID: 22267185
DOI: 10.1093/annonc/mdr629

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / adverse effects*
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Male
Stevens-Johnson Syndrome / chemically induced*

Substances

Antibodies, Monoclonal